MATEON’S GLOBAL STUDY FOR ARTEMISININ INTERVENTION AGAINST COVID-19 CLEARED FOR PATIENT ENROLLMENT IN INDIA.

NEXT STORY
InflaRx Announces Initiation of Phase III Part of Phase II/III Clinical Trial with IFX-1 in Severe COVID-19 Induced Pneumonia
PREV STORY
SpringWorks Therapeutics Announces Clinical Collaboration with Janssen to Evaluate Nirogacestat in Combination with Teclistamab in Patients with Relapsed or Refractory Multiple Myeloma
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Global Heart-on-a-chip Market and Brain-on-a-chip Market Size to 2027 | Innovative Technology, Upcoming Trends and Challenges, Growth Factors, Product and Service, Future Strategic Planning, Key Vendors, Market Contribution and Developments

author_avatar
NASDAQ Market News

Longeveron Announces Initiation of Phase 2a Clinical Trial of Lomecel-B for the Treatment of Alzheimer’s Disease

author_avatar
NASDAQ Market News

FDA Approves New Indication for ENVARSUS XR® (tacrolimus extended-release tablets)

Company Release no. 22/2018 To: NASDAQ Copenhagen A/S                                             Copenhagen, Denmark, 19 December 2018 ...

author_avatar
NASDAQ Market News